The makers of the Covishield vaccine, AstraZeneca, have acknowledged for the first time that the vaccine may lead to a rare side effect called Thrombosis with Thrombocytopenia Syndrome (TTS). This comes as the company is being sued in a class action and could result in a significant legal payout. Public health experts explain that TTS is a rare condition that has been observed as a potential adverse effect of certain COVID-19 vaccines, including Covishield. They also stress the importance of early detection and treatment of TTS for recovery, and believe that AstraZeneca's admission could lead to enhanced safety monitoring and regulatory oversight for vaccines.
Covishield Vaccine Raises Concerns with Rare Blood Clot Syndrome
Background
Covishield is a COVID-19 vaccine developed by the Serum Institute of India and licensed by AstraZeneca. It is widely used in many countries around the world, including India, Brazil, Argentina, and the United Kingdom.
Thrombosis with Thrombocytopenia Syndrome (TTS)
In recent months, concerns have emerged about the potential link between Covishield and a rare side effect called Thrombosis with Thrombocytopenia Syndrome (TTS). TTS is a condition characterized by blood clots in unusual locations accompanied by low platelet counts.
AstraZeneca Acknowledges Link
On April 7, 2022, AstraZeneca acknowledged for the first time that its vaccine may lead to TTS. This admission came after the company was sued in a class action lawsuit for allegedly failing to adequately warn about the risk of this side effect.
Public Health Experts React
Public health experts have stressed that TTS is a rare condition, but its association with certain COVID-19 vaccines, including Covishield, has been observed. They emphasize the importance of early detection and treatment of TTS for recovery.
AstraZeneca's admission of the potential link between its vaccine and TTS is expected to lead to enhanced safety monitoring and regulatory oversight for vaccines.
Top 5 FAQs and Answers
1. What is Thrombosis with Thrombocytopenia Syndrome (TTS)?
TTS is a rare condition that involves the formation of blood clots in unusual locations, combined with a low platelet count. It can be life-threatening if not treated promptly.
2. Is TTS associated with all COVID-19 vaccines?
TTS has been observed in association with certain COVID-19 vaccines, including the AstraZeneca vaccine. However, the risk is extremely rare, affecting only a tiny fraction of people who receive the vaccine.
3. What are the symptoms of TTS?
Symptoms of TTS can include sudden onset of severe headache, blurred vision, chest pain, shortness of breath, and swelling or pain in the legs. If you experience any of these symptoms after receiving a COVID-19 vaccine, seek medical attention immediately.
4. What is the treatment for TTS?
TTS is treated with anticoagulants (blood thinners) and intravenous immunoglobulin (IVIG) to manage the blood clotting and platelet deficiency, respectively. Early diagnosis and treatment are critical for recovery.
5. Is it safe to receive the Covishield vaccine?
The Covishield vaccine is safe and effective for most people. The risk of TTS is extremely low, and the benefits of vaccination far outweigh the potential risks. It is important, however, to be aware of the potential side effects and to seek medical attention if you experience any unusual symptoms after vaccination.
A team of archaeologists from the Vindolanda Charity Trust in northern England has discovered a collection of Roman shoes, all measuring over 30 centimeters long, at the Magna Roman Fort in Northumberland. These "giant" shoes, equivalent to size 49 in Europe and size 15 in the US, have left experts baffled as they search for an explanation for their unusual size. The team is now speculating on who may have worn these shoes, and what their presence at this particular site may signify. This discovery sheds new light on the daily life of Roman soldiers stationed at the Hadrian's Wall World Heritage Site.
"India's Young Cricket Captain Leads the Way: Breaking Records and Comparisons to Legends" Shubman Gill has stepped up as the new captain of the Indian cricket team and proves he is turning out to be a star in his own right. In just his 34th Test, Gill surpassed Sachin Tendulkar's highest score and has outperformed Virat Kohli as well. His leadership skills and batting prowess have earned him recognition and praise from fans and even exhausted opponents. Despite criticism, Gill stayed true to his own tactics and proved himself with an epic inning of 269. He has set a high standard for himself and the Indian team as they continue the series against England.
WHO has released its first-ever global guideline on managing sickle cell disease (SCD) during pregnancy, highlighting the dangers faced by women and their babies. SCD is an inherited blood disorder with potentially fatal consequences, and the health risks intensify during pregnancy. The new guideline aims to improve outcomes for pregnant women with SCD and calls for more investment in evidence-based treatments and disease awareness. With SCD on the rise globally, increasing numbers of maternity care providers need to be equipped to handle its challenges.
On Thursday, March 19 at 5:01 a.m. ET, the vernal equinox or the first day of spring will take place in the Northern Hemisphere. This marks the beginning of the season of longer days and warmer weather as the sun's rays fall directly on the equator. Despite popular belief, day and night are not exactly the same length on the equinox due to atmospheric refraction. The summer and winter solstices and the autumnal equinox also have significant impacts on the Earth's tilt and the length of daylight hours.
A new, inexpensive Arduino-based logger has been developed for accurately mapping the depths of water bodies. By using budget-friendly hardware such as a GPS module and an SD card, combined with a standard NMEA capable echolot sounder, this device is accessible and practical for scientists, recreational enthusiasts, and more. With the added use of Python and matplotlib, users can now easily transform the collected data into detailed depth maps, revealing vital information about water levels and shallow spots in various environments.
After a 28-hour journey through space, Group Captain Shukla has become the first Indian to board the International Space Station (ISS). Accompanied by three other astronauts from the Axiom-4 mission, the ISS is now hosting a total of 11 people. Shukla was welcomed with hugs by the astronauts already stationed at the ISS and presented with the astronaut number 634. As the pilot of the mission, Shukla was given a number ahead of his fellow rookie astronauts and was offered a liquid diet to refresh himself before exploring the six-bedroom facility in space.
Indian astronaut Shubhanshu Shukla has successfully docked with the International Space Station on the Axiom Mission 4. This marks a proud milestone in Indian space history, as Shukla becomes the first Indian to reach the ISS. The docking process involved intricate procedures, and upon arrival, Shukla and his crew were welcomed with warm hugs and will conduct various experiments during their 14-day mission on the ISS.
After a 28-hour journey, Indian astronaut Shubhanshu Shukla and three other astronauts were welcomed onto the International Space Station (ISS) by the expedition team. Shukla expressed his gratitude and excitement for the 14-day mission, where they will conduct scientific experiments and interact with people on Earth. He also shared his amazement at the view and the warm welcome he received from the ISS crew.
Indian astronaut Shubhanshu Shukla has been launched to the International Space Station as part of the Axiom 4 mission aboard the SpaceX Dragon spacecraft. The spacecraft is currently en route to the ISS and is expected to dock with the Harmony module on June 26. The mission, led by Peggy Whitson, will last for two weeks and include scientific research, outreach activities, and commercial projects. Shubhanshu Shukla is joined by mission specialists from ESA and HUNOR. Get to know all about this historic mission carrying an Indian astronaut to space after 40 years.
After multiple delays, the Axiom-4 mission has finally launched with Indian astronaut Shubhanshu Shukla onboard for an important space mission. The spacecraft, carrying Shukla as the pilot along with three other astronauts, will dock at the International Space Station in a few hours. This joint mission between India, Poland, and Hungary marks a significant step in international human spaceflight collaborations and showcases India's ambitions in global space exploration. Shukla's journey not only symbolizes India's return to human spaceflight but also propels the country's human space program to new heights.